Short, frequent, light‐intensity walking activity improves postprandial vascular‐inflammatory biomarkers in people with type 1 diabetes: The SIT‐LESS randomized controlled trial

Documenti analoghi

• Use of adjunctive glycaemic agents with vascular protective properties in individuals with type 1 diabetes: Potential benefits and risks
  di: Ahmad M. Rajab, et al.
  Pubblicazione: (2025)
• Interrupting prolonged sitting reduces postprandial GIP but not GLP ‐1 responses in type 2 diabetes
  di: Beth K. Logan, et al.
  Pubblicazione: (2025)
• Quantitative proteomics identifies plasma protein alterations that associate with metabolic and thrombotic profile changes after bariatric surgery
  di: Hasnain Ahmed, et al.
  Pubblicazione: (2025)
• Fasting and postprandial kidney haemodynamic effects of empagliflozin and linagliptin in mono‐ and combination therapy compared to gliclazide in overweight people with type 2 diabetes ( RACELINES ): A randomised, double‐blind trial
  di: Michaël J. B. van Baar, et al.
  Pubblicazione: (2025)
• Gastric emptying is slower in women than men with type 2 diabetes and impacts on postprandial glycaemia
  di: Chunjie Xiang, et al.
  Pubblicazione: (2024)